REVIEW
Accepted on 11 Mar 2025
Methyltransferase-like 3-mediated RNA N 6 -methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target
doi 10.3389/fimmu.2025.1523503
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Post-Transcriptional Modifications in Cancer Immunity and Immunotherapy
Post-Transcriptional Modifications in Cancer Immunity and Immunotherapy
1,325
Total downloads
5,393
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 11 Mar 2025
PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy
doi 10.3389/fimmu.2025.1537615
- 102 views
ORIGINAL RESEARCH
Published on 04 Dec 2024
Alternative splicing regulation by tumor suppressing subtransferable candidate 4: a pathway to tumor suppression
doi 10.3389/fimmu.2024.1474527
- 681 views
MINI REVIEW
Published on 11 Jul 2024
Neoantigens in cancer immunotherapy: focusing on alternative splicing
doi 10.3389/fimmu.2024.1437774
- 2,393 views
- 7 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: